Literature DB >> 32488274

Causes and prognosis of symptomatic pericardial effusions treated by pericardiocentesis in an Asian academic medical centre.

Xian Pei Cheong1, Lawrence Ka Peng Law1, Swee-Chong Seow1, Lik Wui Edgar Tay1, Huay Cheem Tan1, Wee Tiong Yeo1, Adrian F Low1, Pipin Kojodjojo1.   

Abstract

INTRODUCTION: This study aimed to investigate the causes, clinical management and outcomes of clinically significant pericardial effusions, and evaluate the practice of pericardiocentesis within an academic medical centre in Singapore, a multiethnic country in Southeast Asia.
METHODS: Consecutive patients undergoing pericardiocentesis at a single Asian academic medical centre were identified. Patient demographics, echocardiographic findings, investigations, pericardiocentesis procedural details and clinical progress were tracked using a comprehensive electronic medical records system.
RESULTS: Of 149 patients who underwent pericardiocentesis, malignancy (46.3%) was the most common cause of pericardial effusions, followed by iatrogenic postsurgical complications (17.4%). 77.3% of effusions were large and 69.8% demonstrated tamponade physiology. Pericardiocentesis guided by echocardiography and fluoroscopy was successful in 99.3% of patients and had a complication rate of 2.0%. Likelihood of effusion recurrence and survival to discharge was determined by the aetiology of the pericardial effusion. 24.6% of malignant effusions recurred, and the survival rate 12 months after drainage of a malignant pericardial effusion was 45.0%. Short-term mortality was highest among patients presenting with tamponade due to acute aortic syndromes and those with myocardial rupture due to ischaemic heart disease.
CONCLUSION: Cancer and iatrogenic complications were the most common causes of pericardial effusion in this large cohort of Singapore patients. Pericardiocentesis has a high success rate and relatively low complication rate. Prognosis and clinical course after pericardiocentesis are determined by the underlying cause of the pericardial effusion. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  pericardial effusion; pericardiocentesis; tamponade

Mesh:

Year:  2019        PMID: 32488274      PMCID: PMC7905117          DOI: 10.11622/smedj.2019065

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  13 in total

1.  Epidemiology of pericardial effusions at a large academic hospital in South Africa.

Authors:  H Reuter; L J Burgess; A F Doubell
Journal:  Epidemiol Infect       Date:  2005-06       Impact factor: 2.451

2.  Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis.

Authors:  Shomron Ben-Horin; Ilan Bank; Ami Shinfeld; Erez Kachel; Victor Guetta; Avi Livneh
Journal:  Am J Cardiol       Date:  2007-03-19       Impact factor: 2.778

3.  The usefulness of diagnostic tests on pericardial fluid.

Authors:  D G Meyers; R E Meyers; T W Prendergast
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

4.  Cause and Long-Term Outcome of Cardiac Tamponade.

Authors:  Cristina Sánchez-Enrique; Iván J Nuñez-Gil; Ana Viana-Tejedor; Alberto De Agustín; David Vivas; Julián Palacios-Rubio; Jean Paul Vilchez; Alberto Cecconi; Carlos Macaya; Antonio Fernández-Ortiz
Journal:  Am J Cardiol       Date:  2015-12-07       Impact factor: 2.778

5.  Differentiation between Transudate and Exudate in Pericardial Effusion has almost no Diagnostic Value in Contemporary Medicine.

Authors:  Sukru Akyuz; Emre Arugaslan; Ahmet Zengin; Tolga Onuk; Ufuk Sadik Ceylan; Baris Yaylak; Tugba Kemaloglu-Oz; Baris Gungor; Nese Cam
Journal:  Clin Lab       Date:  2015       Impact factor: 1.138

6.  Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients.

Authors:  W Ma; J Liu; Y Zeng; S Chen; Y Zheng; S Ye; L Lan; Q Liu; H-J Weig; Q Liu
Journal:  Herz       Date:  2011-02-09       Impact factor: 1.443

7.  Echo-guided pericardiocentesis in patients with clinically significant pericardial effusion. Outcomes over a 10-year period.

Authors:  S Akyuz; A Zengin; E Arugaslan; S Yazici; T Onuk; U S Ceylan; B Gungor; U Gurkan; T Kemaloglu Oz; H Kasikcioglu; N Cam
Journal:  Herz       Date:  2014-12-11       Impact factor: 1.443

8.  2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Yehuda Adler; Philippe Charron; Massimo Imazio; Luigi Badano; Gonzalo Barón-Esquivias; Jan Bogaert; Antonio Brucato; Pascal Gueret; Karin Klingel; Christos Lionis; Bernhard Maisch; Bongani Mayosi; Alain Pavie; Arsen D Ristic; Manel Sabaté Tenas; Petar Seferovic; Karl Swedberg; Witold Tomkowski
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

9.  Pericardiocentesis guided by 2-D echocardiography: the method of choice for treatment of pericardial effusion.

Authors:  M Lindenberger; M Kjellberg; E Karlsson; B Wranne
Journal:  J Intern Med       Date:  2003-04       Impact factor: 8.989

10.  Prognosis of large, symptomatic pericardial effusion treated by echo-guided percutaneous pericardiocentesis.

Authors:  Uk Hyun Kil; Hae Ok Jung; Yoon Seok Koh; Hun Jun Park; Chan Seok Park; Pum Joon Kim; Sang-Hong Baek; Ki-Bae Seung; Kyu-Bo Choi
Journal:  Clin Cardiol       Date:  2008-11       Impact factor: 2.882

View more
  5 in total

1.  Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?

Authors:  Bei-Ning Wang; Yu-Xi Li; Wei Ma; Song-Yun Chu; Zhi-Hao Liu; Wen-Hui Ding; Jian-Ping Li
Journal:  J Geriatr Cardiol       Date:  2020-11-28       Impact factor: 3.327

2.  Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion.

Authors:  Takashi Nakamura; Mana Okune; Masakazu Yasuda; Heitaro Watanabe; Masafumi Ueno; Kenji Yamaji; Kazuki Mizutani; Takashi Kurita; Gaku Nakazawa
Journal:  BMC Cardiovasc Disord       Date:  2021-06-03       Impact factor: 2.298

3.  The safety of pericardiocentesis in patients under antithrombotic therapy: A single-center experience.

Authors:  Yuansong Zhu; Chengxiang Zhang; Yuqiao Xie; Bryan Richard Sasmita; Zhenxian Xiang; Yi Jiang; Ming Gong; Yaxin Wang; Siyu Chen; Suxin Luo; Bi Huang
Journal:  Front Cardiovasc Med       Date:  2022-09-21

4.  Unveiling the causes of pericardial effusion in a contemporary case series of pericardiocentesis in Latin America.

Authors:  Juan Hernando Del Portillo-Navarrete; Alejandro Pizano; Jhonattan Benavides; Andres M Palacio; Karen Moreno-Medina; Jaime Cabrales; Darío Echeverri
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

5.  Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes.

Authors:  Andrea Pennacchioni; Giulia Nanni; Fabio Alfredo Sgura; Jacopo Francesco Imberti; Daniel Enrique Monopoli; Rosario Rossi; Giuseppe Longo; Salvatore Arrotti; Marco Vitolo; Giuseppe Boriani
Journal:  Intern Emerg Med       Date:  2021-02-22       Impact factor: 3.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.